ERCC2 and urinary bladder carcinoma: Only one study has reported the presence of LOH in tumors from patients with ERCC2 germline mutations, and this has been found in bladder cancer patients carrying the p.Arg616Pro mutation in ERCC2 (Carlo et al., 2020).